BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frere C, Crichi B, Lejeune M, Spano JP, Janus N. Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants? Cancers (Basel) 2020;12:E917. [PMID: 32283621 DOI: 10.3390/cancers12040917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Frere C, Connors JM, Farge D. Management of Cancer-Associated Thrombosis: An Evolving Area. Cancers (Basel) 2020;12:E2999. [PMID: 33081109 DOI: 10.3390/cancers12102999] [Reference Citation Analysis]
2 Dong S, Zhang Y, Li Y, Li Y, Miao Y, Zhao R, Zhai S. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis. Ann Pharmacother 2021;55:430-9. [PMID: 32938202 DOI: 10.1177/1060028020960037] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Oliveira TB, Mesía R, Falco A, Hsieh JC, Yokota T, Saada-Bouzid E, Schmitz S, Elicin O, Giacomelli L, Bossi P. Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion. Crit Rev Oncol Hematol 2021;157:103200. [PMID: 33321152 DOI: 10.1016/j.critrevonc.2020.103200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]